Skip to main content

Day: May 22, 2023

Diana Shipping Inc. Announces Time Charter Contract for m/v Selina With Cargill

ATHENS, Greece, May 22, 2023 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Cargill International S.A., Geneva, for one of its Panamax dry bulk vessels, the m/v Selina. The gross charter rate is US$12,000 per day, minus a 4.75% commission paid to third parties, for a period until minimum September 15, 2024 up to maximum November 15, 2024. The charter commenced on May 20, 2023. The “Selina” is a 75,700 dwt Panamax dry bulk vessel built in 2010. The employment of “Selina” is anticipated to generate approximately US$5.71 million of gross revenue for the minimum scheduled period of the time charter. Diana...

Continue reading

BIMI International Medical Inc. Announces First Quarter 2023 Financial Results

NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) — BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months ended March 31, 2023. The Company reported a significant decrease in net losses and notable improvements in working capital, underlining the ongoing success of its business strategy and operational effectiveness. Revenues for the three months ended March 31, 2023 and 2022 were $3,197,637 and $2,714,711, respectively. The revenues for the three months ended March 31, 2023 were primarily attributable to the revenues from sales of healthcare products by Phenix Bio Inc., a newly acquired subsidiary, and  from the wholesale sales of generic drugs and medical devices. The $482,926 increase in revenues is mainly due to the $2,022,508 of sales of healthcare...

Continue reading

Cricut, Inc. Declares Special Cash Dividend of $1.00 Per Share

SOUTH JORDAN, Utah, May 22, 2023 (GLOBE NEWSWIRE) — Cricut, Inc. (NASDAQ: CRCT) (“Cricut,” the “Company” or “we”) today announced that the Board of Directors, through its Audit Committee, has declared a special, one-time cash dividend of $1.00 per share to holders of the Company’s Class A and Class B Common Stock. The dividend is payable on July 17, 2023, to stockholders of record at the close of business on July 3, 2023. The aggregate amount of the cash payment to be made in connection with this special dividend will be approximately $234 million. In addition, holders of restricted stock units that are unvested on the record date will be credited with a dividend equivalent based on the value of the per share dividend pursuant to the terms of the Company’s equity incentive documents. The dividend equivalent will entitle such holders...

Continue reading

German American Announces Chairman of the Board and President Transition

Chairman of the Board and CEO D Neil DaubyPresident and Chief Financial Officer Bradley M RustJASPER, Ind., May 22, 2023 (GLOBE NEWSWIRE) — The Board of Directors for German American Bancorp, Inc. (GABC) announced next steps in leadership succession by appointing current Director and Chief Executive Officer, Neil Dauby, to succeed retiring Mark Schroeder as Chairman of the Board, and Brad Rust as President for both the holding company and the bank. Tom Seger, lead director for GABC, stated “The Board, along with the entire GABC family, are extremely grateful to Mark for his longevity and dedicated service to German American. His board and executive leadership and strong counsel throughout his extensive career enabled the company to grow its footprint, product and service offerings, and employment base as the company grew...

Continue reading

Vistin Pharma ASA: Minutes from the Annual General Meeting 2023

Oslo, Norway, 22 May 2023 Vistin Pharma ASA (OSE: VISTIN): Please find attached the minutes from the Annual General Meeting held today, on the 22 May 2023. All matters were resolved as proposed in the call for the Annual General Meeting. For further information, please contact: Alexander KarlsenCFO+47 97 05 36 21alexander.karlsen@vistin.comThis information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.  AttachmentMinutes from AGM 22 may 2023_Vistin Pharma ASA

Continue reading

Aligned Data Centers Completes Acquisition of ODATA

Expansion Into LATAM Market Establishes Company as One of the Largest Private Data Center Operators in the AmericasAligned Data Centers Completes Acquisition of ODATA The transaction positions Aligned among the largest private data center operators in the Americas.DALLAS, May 22, 2023 (GLOBE NEWSWIRE) — Aligned Data Centers, a leading technology infrastructure company offering innovative, sustainable and adaptive scale data centers and build-to-scale solutions for global hyperscale and enterprise customers, today announces it has completed the acquisition of LATAM data center provider ODATA. The transaction positions Aligned among the largest private data center operators in the Americas, with a footprint spanning in excess of 2.5 GW of critical capacity across over 40 data centers at full buildout. ODATA will now operate...

Continue reading

Mizuho to Acquire Premier M&A Advisory Firm Greenhill

Purchase price $15 per share in cash Greenhill to serve as the M&A and restructuring advisory business of Mizuho Greenhill brand, global network, leadership and team to remain in place Acquisition accelerates Mizuho’s investment banking growth strategy, building on its leading capital markets and banking capabilitiesTOKYO and NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) — Mizuho Financial Group, Inc. (TSE: 8411 and NYSE: MFG) and Greenhill & Co., Inc. (NYSE: GHL) today announced a definitive agreement for Mizuho to acquire Greenhill in an all-cash transaction at $15 per share, reflecting an enterprise value of approximately $550 million, including assumed debt. Through this transaction, Mizuho will accelerate its investment banking growth strategy, building on Greenhill’s 27-year history of advising important clients on...

Continue reading

CTO Realty Growth Declares Dividends For the Second Quarter 2023

WINTER PARK, Fla., May 22, 2023 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) announced today that its Board of Directors has authorized, and the Company has declared a quarterly cash dividend of $0.38 per share of common stock for the second quarter of 2023 (the “Common Stock Cash Dividend”). The Common Stock Cash Dividend represents a 1.8% year-over-year increase as compared to the Company’s second quarter 2022 common stock cash dividend and an annualized yield of approximately 9.4% based on the closing price of the common stock on May 19, 2023. The Common Stock Cash Dividend is payable on June 30, 2023, to stockholders of record as of the close of business on June 8, 2023, and the ex-dividend date for the Common Stock Cash Dividend is June 7, 2023. The Board of Directors also authorized, and...

Continue reading

Alpine Income Property Trust Declares Dividend For the Second Quarter 2023

WINTER PARK, Fla., May 22, 2023 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that its Board of Directors has authorized, and the Company has declared a quarterly cash dividend of $0.275 per share of common stock for the second quarter of 2023 (the “Common Stock Cash Dividend”). The Common Stock Cash Dividend represents a 1.9% year-over-year increase as compared to the Company’s second quarter 2022 common stock cash dividend and an annualized yield of approximately 7.0% based on the closing price of the common stock on May 19, 2023. The Common Stock Cash Dividend is payable on June 30, 2023, to stockholders of record as of the close of business on June 8, 2023, and the ex-dividend date for the Common Stock Cash Dividend is June 7, 2023. About Alpine Income Property Trust, Inc. Alpine...

Continue reading

Centessa Pharmaceuticals Receives Fast Track Designation from the U.S. FDA for SerpinPC for Hemophilia B

BOSTON and LONDON, May 22, 2023 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SerpinPC, an investigational novel inhibitor of activated protein C (APC) being developed for the treatment of hemophilia B, with or without inhibitors.  “We are pleased with the FDA’s decision to grant Fast Track designation for SerpinPC as we continue to advance the PRESent registrational studies for SerpinPC in hemophilia B,” said Saurabh Saha MD PhD, Chief Executive Officer of Centessa. “This designation is important recognition of SerpinPC’s novel mechanism of action and underscores the critical need...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.